BubR1 is a key protein mediating spindle checkpoint activation. Loss of this checkpoint control results in chromosomal instability and aneuploidy. The transcriptional regulation of the cell cycle regulated human BUB1B gene, which encodes BubR1, was investigated in this report. A minimal BUB1B gene promoter containing 464 bp upstream from the translation initiation codon was sufficient for cell cycle regulated promoter activity. A pivotal role for transcription factor hStaf/ZNF143 in the expression of the BUB1B gene was demonstrated through gel retardation assays, transient expression of mutant BUB1B promoter-reporter gene constructs and chromatin immunoprecipitation assay. Two phylogenetically conserved hStaf/ZNF143-binding sites (SBS) were identified which are indispensable for BUB1B promoter activity. In addition, we found that the domain covering the transcription start sites contains conserved boxes homologous to initiator (Inr), cell cycle dependent (CDE) and cell cycle genes homology regions (CHR) elements. Mutations within the CDE and CHR elements led to diminished cell cycle regulation of BUB1B transcription. These results demonstrate that BUB1B gene transcription is positively regulated by hStaf/ZNF143, a ubiquitously expressed factor, and that the CDE-CHR tandem element was essential for G2/M-specific transcription of the BUB1B gene.
INTRODUCTION
The spindle checkpoint functions to prevent premature anaphase entry until all chromosomes have completely aligned at the metaphase plate. BubR1 is a key protein mediating spindle-checkpoint activation during which it is phosphorylated. A loss of spindle-checkpoint function inevitably results in chromosomal instability and aneuploidy (1, 2) . Given that aneuploidy is prevalent in many types of cancers, it is believed that spindlecheckpoint failure may be at least partly responsible for the development of cancer (3) . Mouse genetics study showed also that haplo-insufficiency of BubR1 resulted in enhanced genomic instability and development of lung and colon cancer (4, 5) . In synchronized cells, expression of the BUB1B gene, which encodes BubR1, is undetectable in G1 but it peaks in G2/M (6, 7) . This cell cycle dependent expression explains the tissue distribution and the abundance of BubR1 mRNA in cells with a high mitotic index (8) . In this work, which represents the first report concerning the regulation of BUB1B gene expression, we localized the promoter of this gene to positions À464/À107 relative to the translation initiation codon. We found that the BUB1B promoter contains three positively cis-acting motifs: one Inr-like motif and two elements recognized by the hStaf/ZNF143 transcription factor. This factor can up-regulate the BUB1B promoter activity, and chromatin immunoprecipitation assays demonstrated that the endogenous hStaf/ZNF143 is bound to the BUB1B promoter in vivo. The ZNF143 protein is the human ortholog of Staf, the Xenopus selenocysteine tRNA Sec gene transcription factor (9, 10) . The human Staf (hStaf/ZNF143) is a seven C2-H2 zinc finger protein capable of enhancing transcription of the tRNA Sec but also of the snRNA and snRNA-type genes (10, 11) . hStaf/ZNF143 can also stimulate transcription from an mRNA-type pol II promoter (10, 12, 13) . To date, only seven protein-coding genes have been described to be regulated by hStaf/ZNF143: the cytosolic chaperonin containing t-complex polypeptide 1 (TCP1) (14) ; the interferon regulatory factor (IRF3) (15) ; the neuronal nitric-oxide synthase (NOS1) (16) ; the transaldolase (TALDO1) (17) ; the aldehyde reductase (AKR1A1) (18) ; the mitochondrial ribosomal protein S11 (MRPS11) (19) and the synaptobrevin-like 1 (SYBL1) (20) . In addition, vertebrates contain the ZNF76 protein which constitutes a ZNF143 paralog (13, 21) . ZNF76 and ZNF143 are basically considered to play the same role even though their relative expression levels differ in various tissues (13) . However, recent results suggested that ZNF76 functions as a transcriptional repressor through its interaction with TBP and that sumoylation modulates its transcriptional properties (22) . Very recently, genome-wide analysis led us to identify 1175 hStaf/ZNF143-binding sites distributed in 938 mammalian promoters in protein-coding genes. By extrapolating these values to the full sizes of the genomes, we can infer the existence of at least 2500 Staf-binding sites (SBS) distributed in 2000 promoters. This large number suggests that the SBS constitutes one of the most widespread transcription factor binding sites in mammalian promoters (23) .
In G1/S, the transcriptional repression of many genes such as CDC25C, CDC2, CCNA2 (coding for cyclin A), PLK1 (polo-like kinase) and RB6K (rabkinesine 6) is regulated by two repressor elements known as CDE (cell cycle dependent element) and CHR (cell cycle genes homology region). In these genes, mutation of the CDE and CHR elements allowed elevated transcription during G1 and the consequent loss of cell cycle regulated expression (24) (25) (26) (27) . In the present study, we demonstrate that the cell cycle regulation of BUB1B gene transcription is also achieved through the presence of two elements homologous to the repressor elements CDE and CHR.
MATERIALS AND METHODS

Reporter constructs and expression vectors
The human BUB1B promoter fragment À1185/À31 was PCR amplified from human genomic DNA using direct and reverse primers incorporating SacI and BamHI sites, respectively. The amplified product was cloned directly at the 5 0 -end to the luciferase reporter gene into the SacI/ BamHI digested pFLASH I vector (SynapSys). The 5 0 -end truncated derivatives of the À1185/À31 fragment (À864/À31, À585/À31, À464/À31, À314/À31, À305/ À31, À236/À31 and À107/À31) were PCR amplified from construct À1185/À31 and ligated to SacI/BamHI cut pFLASH I. Mutant constructs were generated by using the QuickChange II XL site-directed mutagenesis kit (Stratagene). All constructs were verified by automated DNA sequencing. Constructs À464/À31 mCHR contain the À176ATTTGAA-170 to À176CGGGTCC-170 substitution, À464/À31 mCDE contain the À166TGGCGG-161 to À166GTTATT-161 substitution. The Drosophila expression vectors pPAC-ZNF76 and pPAC-ZNF143 containing the human ZNF76 and ZNF143 cDNAs were described in (13) . The oligonucleotide sequences used in this study are available on request.
Transfection and luciferase assays COS-7 cells were transfected by the calcium phosphate co-precipitation procedure with 1 mg of reporter construct, 0.5 mg of pCH110 plasmid as the internal control, and carrier DNA to bring up the total DNA content to 10 mg/ plate. SL2 Drosophila cells were transfected as described in (12) with 25, 100 or 500 ng of pPAC-hStaf/ZNF143 or pPac-ZNF76, and 200 ng of pACH110 as internal control. After 48 h, cells were lysed and the b-galactosidase activity was measured as previously described (12) . The luciferase assay was performed as recommended by the manufacturer (Promega). The luciferase activity was normalized to the b-galactosidase activity. Each transfection experiment was done in triplicate.
hStaf/ZNF143 protein preparation and DNA-binding assay
The hStaf/ZNF143 DNA-binding domain was produced using the glutathione S-transferase (GST) gene fusion system. Briefly, the DNA containing the Staf zinc finger coding region between A264 and E472 was excised from E10 (10) as a HindIII/EcoRV fragment, blunted and inserted in the direct orientation into the SmaI site of pGEX-2TK (GE Healthcare). The fusion protein was purified using glutathione-sepharose beads. The glutathione S-transferase moiety was cleaved with thrombin. Full-length hStaf/ZNF143 was synthesized by in vitro coupled transcription-translation with the TnT system (Promega) as described in (13) . Fifty microliter reactions were programmed with 1 mg of pSK(-)-ZNF143 (13) . Gel retardation assays were performed essentially as described in (28) with 20 fmol of the labeled probe in the presence of either the hStaf/ZNF143 DBD (1, 2, 4 and 20 pmol), 2.5 and 5 ml of programmed lysate or 10 mg of HeLa cells nuclear extracts. The various probes containing the wild-type and mutant versions of the SBS in the BUB1B promoter were generated by PCR amplification of regions À342/À196, À342/À265, À281/À196 using 32 Plabeled oligonucleotides.
ChIP assay
The rabbit polyclonal antipeptide antibody against a C-terminal epitope of the Xenopus Staf (29) was used for ChIP as essentially described in (23, 30 Cell culture, synchronization and cell cycle analysis Transiently transfected COS-7 cells were arrested at the G1/S boundary by a single or double thymidine block. To block them at the M phase, cells were treated with nocodazole. In brief, for thymidine block and nocodazole treatment, thymidine or nocodazole were added 18 h after transfection to 2 mM or 0.17 mM final concentration, respectively. After 22 h incubation, cells were harvested and used for luciferase and flow cytometry assays. For the double thymidine block, thymidine was added to 2 mM as the first block. After a 16 h incubation, cells were washed twice with PBS and incubated in complete growth media for an additional 8 h. Thymidine was then added as the second block for 16 h. Subsequently, cells were washed twice with PBS, and complete growth media was added to release them from the block. This time point was set as 0. Cells were harvested at various time points and used for luciferase and flow cytometry assays. For flow cytometry, cells were briefly trypsinized, pelleted by centrifugation at 200 g, resuspended in PBS and fixed in 75% ethanol. After centrifugation and rehydration in PBS for 15 min at room temperature, cells were pelleted and resuspended in 1 ml of staining buffer containing propidium iodide (0.5 mg/ml), 0.1% Triton-X100, 0.1 mM EDTA and RNase A (25 mg/ml). Cell cycle distribution was determined by analyzing their DNA content on a Becton Dickinson FACScalibur flow cytometer.
RESULTS
Characterization of the BUB1B promoter
A search at the database of transcription start sites (DBTSS) (31, 32) revealed that transcription of the BUB1B gene is directed from multiple transcription start sites (TSS) located in a 75-bp long region. In this report, promoter numbering starts from the first nucleotide of the translation initiation codon. The TSS region is located between positions À198 and À124, with a major transcription start site at À178 ( Figure 1A ). To identify the regions responsible for transcriptional regulation of BUB1B, we transiently transfected COS-7 cells with several luciferase reporter constructs containing progressively deleted 5 0 -flanking regions of the BUB1B gene and then measured the luciferase activity of the resulting cell extracts ( Figure 1A and B). The parental construct À1185/ À31 contains the region À198/À124 covering the transcription start sites. A deletion from À1185 to À586 resulted in $5-fold decrease of luciferase activity ( Figure 1B , compare constructs À864/À31 and À585/ À31 with À1185/À31). Further deletions from À584 to À306 did not significantly affect the transcriptional activity ( Figure 1B , compare the activity of constructs À464/À31, À314/À31 and À305/À31 with construct À585/À31). An additional deletion to À237 resulted in $10-fold decrease of activity. Strikingly, a further deletion to À107 created a construct unable to drive transcription of the reporter gene ( Figure 1B , compare À236/À31, À107/À31 and the empty vector Luc with À1185/À31). We concluded from the luciferase assays that transcription of the BUB1B gene was positively regulated by two regions, one located between À1185/À585 and the other between À305/À107. (34) . No downstream promoter element (DPE) was found at proximity of the main transcription start site. Interestingly, however, two consensus binding sites for the transcription factor hStaf/ ZNF143 (10, 11, 13) were found in the region À305/À107 which positively regulates BUB1B gene expression. They are called hereafter SBS for simplicity's sake. The first SBS1, located at positions À305/À288, and the second SBS2 at positions À256/À239, were found to be interspecies conserved at 72 and 88%, respectively ( Figure 2A ). In Figure 2B , the 18-bp SBS1 and SBS2 were aligned with the sequence of the human tRNA Sec SBS (11) and with the consensus sequences determined by binding site selection (11, 35) . Immediately, upstream of the two SBS is found an interspecies conserved 7 bp ACTACAA motif ( Figure 2A ), which does not correspond to any binding site for known transcription factors. Furthermore, Figure 2A shows that the À305/À107 region contains blocks of high sequence identity to the CHR (positions À174/À170) and the CDE (positions À165/À161) (see also Figure 6A ). These elements are known to be involved in the cell cycle regulated transcriptional repression of many genes (24) (25) (26) (36) (37) (38) (39) . In the promoter of these genes, the CDE is generally adjacent to or 1-5 bp upstream of the CHR element ( Figure 6A ). This contrasts with the BUB1B promoter where the CDE homologous motif precedes the CHR by 4 bp. Finally, the upstream 5 0 -flanking region of the BUB1B gene contains one CpG island extending from À415 to À50.
hStaf/ZNF143 binds to the BUB1B basal promoter
In the first place, gel retardation assays were performed to determine whether hStaf/ZNF143 does bind the BUB1B promoter. To do this, the 32 P-labeled DNA fragment (À342/À196) encompassing the two putative SBS (probe I in Figure 1A ) was incubated with increasing amounts of the purified hStaf/ZNF143 DNA-binding domain (hStaf/ZNF143 DBD). Figure 3A shows that the hStaf/ZNF143 DBD bound with high yield to the BUB1B promoter. Increasing amounts of the protein generated two retarded complexes (C1 and C2 in Figure 3A , compare lane 1 with lanes 2-5). The C1 and C2 complexes were specific because they were competed out by an excess of unlabeled SBS of the Xenopus tRNA Sec gene ( Figure 3A , lane 6) but not of an unrelated oligonucleotide ( Figure 3A , lane 7). We next examined the binding capacities of the hStaf/ZNF143 DBD to a BUB1B promoter carrying alterations in the SBS. Three mutant versions of the BUB1B promoter were engineered. In mSBS1, the CCCA sequence at positions 3-6 of SBS1 was replaced by AAAC; the same mutation was introduced in the SBS2 sequence to yield mSBS2. The mSBS1-2 construct combined both mutations simultaneously. It appeared that formation of the retarded complexes was strictly dependent on the SBS integrity. Indeed, whereas mSBS1 and mSBS2 enabled formation of one single retarded complex only ( Figure 3B , compare lanes 5-7), the simultaneous presence of both mutations in mSBS1-2 completely abrogated DBD binding ( Figure 3B, lane 8) . The binding to wild-type or mutant BUB1B promoter of the full-length hStaf/ZNF143, produced from programmed rabbit reticulocyte lysate, was further evaluated. As observed with the DBD, increasing amounts of protein generated the characteristic C1 and C2 complexes ( Figure 3C , lanes 2 and 3) which are specific since they disappear in the presence of an excess of the wt SBS but not with an unspecific competitor ( Figure 3C , lanes 4 and 5). This binding pattern is strictly dependent on the SBS integrity because the combined presence of the mSBS1 and mSBS2 mutation totally abrogated hStaf/ZNF143 binding ( Figure 3C, lane 7) .
To ask whether hStaf/ZNF143 is expressed in HeLa cell, we performed gel retardation assays with HeLa cell nuclear extracts and probes II and III containing SBS1 and SBS2, respectively. In such an experiment, we expect finding one single complex with each of the probe. This was effectively the case, as shown in Figure 3D (lanes 2 and 10). The specificity of binding was attested by the competition obtained with an unlabeled hStaf/ ZNF143 consensus oligonucleotide ( Figure 3D , lanes 3, 4, 11) but not with an unrelated unlabeled oligonucleotide ( Figure 3D, lanes 5, 6, 12 ). The presence of hStaf/ZNF143 in the complex was assessed by the displacement of the complexes observed with an anti-hStaf/ZNF143 ( Figure 3D , lanes 7 and 13) but not with a pre-immune antibody ( Figure 3D, lanes 8 and 14) . To further validate these findings, the association of hStaf/ZNF143 to the human BUB1B promoter in vivo was investigated with the chromatin immunoprecipitation assay (ChIP). Chromatin, formaldehyde cross-linked with sheared DNA 0.5-1 kbp in length, was prepared from HeLa cells and incubated with an antipeptide antibody directed against the C-terminal part of hStaf/ZNF143 (29) or with a control pre-immune antibody. The recovered DNA was analyzed by semi-quantitative PCR with primers spanning the SBS of the BUB1B promoter (test sequence) or a region located 2.5 kbp upstream of it (control sequence). The analysis was performed with two dilutions of the DNA obtained from anti-hStaf/ZNF143 and pre-immune ChIP. We also tested a serial dilution of the input material to demonstrate that the PCR was quantitative within a linear range of concentration. A specific signal, absent with the pre-immune antibody, was obtained with the DNA immunoprecipitated with the hStaf/ZNF143 antibody ( Figure 4A , compare lanes 1, 2 and 3, 4 of the test). In contrast, no specific signal could be obtained with the control primer pair ( Figure 4B , lanes 1-4 in the control). As an additional control, the same DNA samples were used to show the binding of hStaf/ZNF143 to the human tRNA Sec gene promoter, known to be targeted by hStaf/ ZNF143 (11) ( Figure 4B ). As expected, a specific signal was obtained only for the PCR reaction using the DNA immunoprecipitated with hStaf/ZNF143 and performed with the test primer pair (compare lanes 2 and 3 of the test and control reactions). Collectively, these results demonstrate the presence of two SBS and the association of hStaf/ZNF143 to the BUB1B promoter in vivo.
Effects of hStaf/ZNF143-binding site and Inr mutations on BUB1B promoter activity
The effect of the debilitating mutations mSBS1, mSBS2 and mSBS1-2 was assessed in vivo by introducing them into construct À464/À31 ( Figure 1C ). The mutant constructs were then transfected into COS-7 cells and promoter activities were reported by the luciferase activity. Mutation of the SBS1 and SBS2 resulted in a slight decrease to 78 and 61% of the wild-type level, respectively ( Figure 1C) . The simultaneous mutation, however, induced a much more pronounced effect since the activity dropped to 19% of the wt level ( Figure 1C ), indicating that SBS1 and SBS2 are of prime importance to BUB1B promoter activity. We also observed that the TTAAATT sequence (positions À180 to À174) is very similar to the Inr consensus sequence YYAN(T/A)YY (34) . To test the functional importance of this interspecies conserved motif, the TTAAATT sequence was changed to TTCCCTT. The activity of the luciferase reporter decreased to 49% of the wild-type level (mInr in Figure 1C) . From this data, we conclude that the SBS are functional and that an Inr-like motif lies in the BUB1B promoter.
Transcriptional activation of the BUB1B promoter in Drosophila Schneider cells
To further confirm the role of hStaf/ZNF143 in BUB1B gene transcription and to investigate whether ZNF76, the human paralog of hStaf/ZNF143, can functionally interact with the BUB1B promoter, transient transfection experiments were performed with Drosophila SL2 cells. This model offers the advantage to lack many of the homologs to vertebrate transcription factors, in particular ZNF143 and ZNF76 (12, 13) . Thus, effectors for ZNF143 (pPac-hStaf/ZNF143), ZNF76 (pPac-ZNF76) (13) and the empty vector pPac under the control of SL2-specific promoter, were co-transfected along with the luciferase reporter gene under the control of the wild-type À436/À31 BUB1B promoter. The effect on promoter activity of varying the intracellular level of ZNF143 or ZNF76 was assessed by introduction of increasing amounts of the expression vectors ( Figure 5A ). Expression from the pPachStaf/ZNF143 or pPac-ZNF76 expression vectors was confirmed by gel retardation assays with SL2 extracts and probe II containing SBS1 ( Figure 1A) . No binding was observed with extracts from untransfected or empty-pPac transfected SL2 cells ( Figure 5B , compare lane 1 with lanes 2 and 3). In contrast, increasing the amount of expression vectors in the transfection led to higher yield of retarded complexes ( Figure 5B , compare lane 1 with lanes 4-6 and 7-9). As ZNF143 and ZNF76 recognize a same DNA motif with identical affinities (13), the yield of the complexes is a gauge of the expression of hStaf/ZNF143 and ZNF76 in SL2 cells ( Figure 5B, lanes 4-9) . In these assays, the luciferase activity in cells extracts was normalized to the amount of the effector proteins. ZNF143 and ZNF76 exhibited a dose dependent transactivation effect on the À464/À31 promoter, reaching 24-fold for ZNF143 and 8-fold for ZNF76 compared to the empty vector pPac ( Figure 5A ). We concluded that ZNF76 and ZNF143 can mediate the transcriptional activation of the BUB1B promoter in Drosophila SL2 cells.
Transcription of BUB1B is regulated during the cell cycle
We next analyzed the cell cycle dependent transcription of BUB1B by assessing the luciferase activities of the À464/ À31 construct transfected into COS-7 cells that had been synchronized in G1/S by a double thymidine block. After the cells were released from the block, the luciferase activities at the indicated time points were measured and normalized ( Figure 6A ). Most the cells were in G1/S at the start of the experiment. As the cells entered in the S phase, the À464/À31 associated luciferase activity increased with an optimum $9-13 h after the release when most of the cells were in G2/M. In contrast, similar experiments using a 3 0 -truncated promoter containing only the two SBS (construct À464/À196) resulted in a significant increase in reporter activity in G1/S which remained high throughout the cell cycle ( Figure 6A ). To test whether the binding of hStaf/ZNF143 to the SBS of the BUB1B promoter is cell cycle dependent, we performed gel retardation assays * * ********* ******* **** -290 h GCGAGTTCGCGGACTAAACA--GGCATAAACTACAAGCCCCAGAATGCCTTGGGCGAGAd ACGACAGTGGGGACTAAACCCCGAGATAAACTACAAGCCCCAGAATGCCTTGGGGGGGGG m GCG-CAGCGCGTGCTTAAACCCGGGATACACTACAATCCCCAGAATGCTTTGGGAGGAGr GCG-CAGCGCGGGCTTAAACCCGGGATGCACTACAATCCCCAGAATGCTTTGGGAGGAG-** * * ** ** * ** ******* *********** ***** *
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Effects of mutations in the CDE and CHR homologous elements on the cell cycle dependent BUB1B transcription activity
The G2/M specific transcription of many genes such as CDC25C, CDC2, CCNA2, PLK1 and RB6K (24, 26, 27, 40) is regulated by a tandem of repressor elements, the cell cycle dependent element (CDE) and the cell-cycle genes homology region (CHR). We found that two sets of sequences at positions À174/À170 and À165/À161 bear a strikingly high similarity to the CHR and CDE consensus sequences (Figure 2A) . The difference resides in their relative organization, 1-5) or the SBS1 and SBS2 mutant version borne by probe I (lanes 6 and 7) were incubated in the absence (lanes 1 and 6) or presence of increasing amounts of rabbit reticulocyte lysate containing full-length hStaf/ZNF143 (lanes 2 and 3). Lane 7 contained the same amount of protein as in lane 3. Lanes 4 and 5 were performed with the same amount of protein as in lane 3 but in the presence of a 1000-fold excess of unlabeled specific (lane 4, wt SBS) and unspecific competitor (lane 5, unsp), respectively. C1 corresponds to both sites of the probe saturated with the protein; the protein binds to one of the sites only in C2. (D) Gel retardation assay with the wt probes II (lanes 1-8) or III (lanes 9-14) in the absence (lanes 1 and 9) or presence (lanes 2-8 and 10-14) of HeLa cell nuclear extracts (NE). The reactions in lanes 3, 4 and 11, 5, 6 and 12, 7 and 13, 8 and 14 were performed in the presence of unlabeled specific competitor (wt SBS), unspecific competitor (unsp), anti-hStaf/ZNF143 and pre-immune antibody, respectively. The specific competitor was added at a 500-fold (lane 3) and 1000-fold molar excess (lanes 4, 11) . A 500 and 1000-fold molar excess of unspecific competitor was contained in lanes 5 and 6, 12 respectively. The arrow points to the complexes mentioned in the text.
the CHR motif lying upstream of the CDE in the BUB1B promoter ( Figure 7A ). These observations suggest that the two putative cis-elements can also function as a G1/Sspecific repressor, as previously reported for the G2/Mspecific genes. To test the hypothesis, we introduced mutations in the putative CHR and CDE motifs (mCHR and mCDE in Figure 7B ). After transfection into COS-7 cells, the luciferase activity was measured in cells arrested in G1/S with thymidine or in G2/M phase transition by nocodazole ( Figure 7C ). Drug treatment resulted in the synchronization of at least 85% of the cells in the various phases as determined by propidium iodine staining and flow cytometry (data not shown). The luciferase activity in extracts of cells transfected with the wild-type À464/À31 and arrested in G1/S was 2.2-fold lower than that from cells arrested in G2/M (Figure 7C and D) . In contrast, transfection of the CHR and CDE mutants of the BUB1B promoter-luciferase constructs abolished cell cycle periodicity and resulted in a 2.8-and 3.1-fold enhanced transcription activity relative to the wild-type level in G1/S arrested cells (Figure 7C and D) . In G2/M arrested cells transfected with the CHR and CDE mutants, however, the measured activities were similar to the wild-type ( Figure 7C and D) . These results strongly suggest that CDE and CHR act as G1/S-specific repressor elements in the BUB1B promoter and are essential for the cell cycle expression of this gene.
DISCUSSION
The BUB1B gene, which is highly expressed in cells with a high mitotic index, exhibits a cell cycle dependent expression with an undetectable transcription in G1 and a gene expression peak in G2/M (6,7). In the present study, we investigated the transcriptional regulation mechanism of the human BUB1B gene. We identified that regions À1185/À585 and À305/À107 in the promoter are involved in the transcriptional regulation of the BUB1 gene. Region À1185 to À585, which performs a positive regulation on BUB1B gene expression, contains two transposable elements. Sequence comparison of the regions homologous to À1185/À585 in other mammalian genomes did not reveal the presence of conserved transcription factor binding sites. This suggests that the positive regulation is performed by species-specific elements. Similar to other cell cycle regulated genes, the BUB1B promoter does not possess a TATA box and, as a consequence, gives rise to many transcription start sites. We identified five interspecies conserved cis-acting elements in the 5 0 -flanking region À305 to À107, and a trans-acting factor involved in the control of BUB1B gene expression. Three cis-acting motifs positively regulate transcription and the other two constitute a cell cycle dependent transcriptional repressor. The motif surrounding the major transcription start site is likely to function as an initiator. The other two positively cis-acting motifs, SBS1 and SBS2, are specifically recognized by hStaf/ZNF143 which itself was found associated to the BUB1B promoter in HeLa cells. Mutations of SBS1 and SBS2, singly or in combination, led to a sharp decrease of reporter activity. Analysis of the BUB1B promoter activity in insect cells demonstrated that hStaf/ ZNF143 and ZNF76 can reconstitute BUB1B promoter activity. Although Staf was originally identified as the transcription factor regulating tRNA Sec gene transcription, it also controls snRNA, snRNA-type and mRNA gene expression (10, 11, (14) (15) (16) (17) (18) (19) (20) 41) . The present study extends the role of hStaf/ZNF143 to BUB1B gene transcription. The two identified SBS1 and SBS2 sites, distant by 31 bp, were found associated to the 7 bp ACTACAA motif which lies immediately 5 0 to the SBS. This motif, under our conditions, is apparently not involved in transcription activity of the BUB1B promoter since we observed that the 5 0 deletion eliminating the ACTACAA sequence did not affect promoter activity. Scrutiny of the sequences flanking the SBS in snRNA and snRNA-type genes did not reveal the presence of an ACTACAA-associated motif. In contrast, it is found in the SBS characterized in the SYBL1 promoter (20) and in 58% of the SBS that we recently identified by a genome scale analysis (23) . The finding that the SBS are essential for expression of the BUB1B gene raises the interesting question of whether hStaf/ZNF143, the main activating factor of the Staf family, is involved alone in transcription activation of the BUB1B gene. Alternatively, could ZNF76 also play a role in the expression of this gene? Although the ChIP assay was performed with antibodies recognizing specifically hStaf/ZNF143, this does not exclude the possibility that ZNF76 can also be involved in BUB1B expression.
The other two cis-acting motifs that we identified are localized in the region covering the transcription start site and we showed that they function as cell cycle dependent repressor elements. They harbor high identity with the consensus sequences of the CDE (G/CGCGG) and CHR (TTGAA) elements identified in the cell cycle regulated promoter genes such as CDC25, CDC2, CCNA2 (coding for cyclin A), PLK1 (polo-like kinase) and RB6K (rabkinesine 6) (24-27). These two elements are known to induce repression of transcription and we established that their mutation led to almost complete impairment of the cell cycle dependent transcription activity of the BUB1B promoter. Worth of note, however, the tandem repressor element is organized in the CHR-CDE configuration in the BUB1B gene whereas the arrangement CDE-CHR occurs in all the other identified repressors.
Careful inspection of the promoter sequences of other genes known to be regulated with a tandem of CDE and CHR repressor elements pointed to the presence of SBS in the promoters of the RBL2 (p130 protein), PLK1 (pololike kinase protein) and BIRC5 (survivin protein) genes (26, 38, 42, 43) (Table 2 ). Studies on genes that are cell cycle regulated by the CDE-CHR tandem of repressor elements (CDC25C, CDC2 and aurora A) revealed that ubiquitously expressed transcription factors such as Sp1, NF-Y and E4TF1 act positively by binding to target sequences upstream of the CDE-CHR motifs (36, 39, 40) . The cell cycle dependent repression of upstream activators via the CDE and CHR elements has been established as the major regulatory mechanism (36, 40) . As shown by genomic footprinting on these promoters, both CDE and CHR elements are protected in a periodic fashion, suggesting involvement of a specific factor. A binding activity termed CDF-1 has been identified and proposed to interact with both CDE and CHR in the CDC25C gene promoter (44) . In a further work, a factor (CHF) interacting specifically with CHR has been isolated in the CCNA2 gene promoter, encoding cyclin A (45). In the situation described for the CDC25C promoter, it was proposed that CDF-1 presumably functions by specifically repressing the NF-Y mediated activation (44) . However, no further characterization of the CDF-1 and CHF complexes was undertaken. Recently, a very interesting mechanism was reported to involve the CDE and CHR elements in chromatin remodeling of the CCNA2 promoter. In this case, the CDE-CHR tandem which is needed for repression in quiescent cells, was also demonstrated to be required for organizing the chromatin structure specific for the inactive promoter (46) . However, this particular nucleosome organization becomes disorganized as a consequence of mutations in the CDE-CHR repressor element. In the case of the BUB1B promoter, we have clearly demonstrated the functionality of the CDE-CHR tandem as a repressor element, but the precise underlying mechanism remains to be investigated.
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